Aspergillosis Treatment
Links shared publicly online about this topic
Aspergillosis: eMedicine Dermatology
emedicine.medscape.com — “Overview: Cutaneous aspergillosis is usually a cutaneous manifestation of disseminated infection with the fungus Aspergillus. Primary cutaneous disease is rare and is most commonly caused by Aspergillus fumigatus and Aspergillus flavus. Rare cutaneous infections have been reported ...” View full resource at emedicine.medscape.com
Most Recently Shared on March 23, 2010 at 5:11 pm By:
Medscape Dermatology Health Site
Cutaneous aspergillosis in an asthma patient--a consequence of steroid treatment? Check the eMedicine update: http://bit.ly/arJ6Cg
Infectious Dis. Medical News about Aspergillosis
mdlinx.com — “Caspofungin Use in Daily Clinical Practice for Treatment of Invasive Aspergillosis” View full resource at mdlinx.com
Most Recently Shared on July 12, 2010 at 11:13 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Caspofungin Use in Daily Clinical Practice for Treatment of Invasive Aspergillosis: BMC Infectious Diseases http://bit.ly/cjfGCy #ID
Phase 3 Study of Vfend & Eraxis Combo Therapy for Invasive Aspergillosis - MPR
empr.com — “Pfizer announced results from its Phase 3 study comparing combination therapy of Vfend (voriconazole; Pfizer) and Eraxis (anidulafungin; Pfizer) to Vfend monotherapy for the treatment of invasive aspergillosis (IA).” View full resource at empr.com
Most Recently Shared on September 30, 2011 at 3:00 pm By:
Phase 3 Study of Vfend & Eraxis Combo Therapy for Invasive Aspergillosis http://ow.ly/6JDTX #infection
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Medscape Dermatology
Latest medical news, articles, and features from Medscape Dermatology.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
